Spokane Expansion
Press Releases
Jubilant HollisterStier Receives Zero Observations from Recent U.S. Food and Drug Administration Inspection
SPOKANE, WA. – Jubilant HollisterStier, a sterile fill-finish and injectable pharmaceutical contract manufacturing organization, announces that a United States Food and Drug Administration (USFDA) inspection, performed by the Center for Biologics Evaluation and...
Jubilant HollisterStier Celebrates the Opening of Their Third Manufacturing Line with a Ribbon Cutting Ceremony
02.09.2024, Spokane, WA – Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line and the groundbreaking of the next phase of their facility expansion. JHS President and CEO...
Ian Fuller Named Vice President of Operations at Jubilant HollisterStier Contract Manufacturing
09.14.2023, Spokane, WA: Jubilant HollisterStier Contract Manufacturing is pleased to announce the appointment of Ian Fuller as the new Vice President of Operations. With over 25 years of progressive management experience in the biotech and pharmaceutical industries,...
Media Mentions
Jubilant HollisterStier Awarded Manufacturer of the Year from the Association of Washington Business
Life Science Washington, an independent, non-profit trade association serving the life sciences industry in the state of Washington, notes Jubilant HollisterStier's win as the Association of Washington Business (AWB) 2024 Manufacturer of the Year.
Jubilant HollisterStier: Scaling Excellence in Pharma Manufacturing
Jubilant HollisterStier CMO is making significant strides in expanding its capabilities to meet global demand for complex formulations and sterile injectables. In this interview with Contract Pharma, CEO Chris Preti shares insights into the company’s ongoing...
Exploring CMO Strategies with Chris Preti (DCAT Week)
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of discussion include operations and the strategic vision at Jubliant HollisterStier, the current...
White Papers
Case Studies
Case Study: FTZ Subzone for API Clearance
Challenge A customer needed to change from a domestically sourced API (active pharmaceutical ingredient) to an alternative, foreign-made API for a commercial product while avoiding any disruption to patient supply during the switch. Approach JHS established a Foreign...
Case Study: Expedited Ointment Project Timeline
Challenge A customer came to our team at JHS to fill GMP (Good Manufacturing Practices) batches to submit a new drug (NDA) of an ophthalmic ointment within a highly expedited timeline. The customer needed two clinical batches and three registration batches within a...
Case Study: Zero Deviations on an Expedited Timeline
Articles
Celebrating Women’s History Month 2025 at JHS
As we celebrate Women's History Month, we want to take a moment to honor the remarkable women who have shaped our industry and continue to drive our success at Jubilant HollisterStier (JHS). This year, we are especially proud to recognize the outstanding women at...
Jubilant HollisterStier is attending DCAT Week 2025: Let’s Connect!
Jubilant HollisterStier is excited to announce our participation in DCAT Week 2025 during March 17-20 in New York City. We’re looking forward to connecting with other leaders to talk about the latest trends in biologics, sterile injectables, and lyophilization at one...
Quality Without Compromise: GMP Annex 1 for Sterile Manufacturing
What is Annex 1? Effective August 2023, GMP Annex 1 establishes the regulatory standard for all sterile medical products sold in the EU and focuses on best practices for aseptic and terminal sterilization. The final section regarding lyophilization protocol became...
Elevating Your Vision with Personalized Support
Contact us today and let’s explore how we can support your next project.